EAM Investors, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 281 filers reported holding HAEMONETICS CORP in Q4 2018. The put-call ratio across all filers is 2.89 and the average weighting 0.1%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2022$1,773,164
-9.7%
22,545
-15.0%
0.37%
-14.1%
Q3 2022$1,964,000
+34.2%
26,532
+18.2%
0.43%
+19.6%
Q2 2022$1,463,000
-33.2%
22,450
+29.3%
0.36%
-38.3%
Q3 2019$2,191,000
+3.4%
17,369
-1.3%
0.58%
+11.8%
Q2 2019$2,118,000
+0.8%
17,596
-16.2%
0.52%
-9.3%
Q4 2018$2,102,000
-48.4%
21,006
-40.9%
0.57%
-5.6%
Q3 2018$4,071,000
+18.8%
35,527
-7.1%
0.60%
+11.8%
Q2 2018$3,428,000
+11.4%
38,228
-9.2%
0.54%
+5.7%
Q1 2018$3,078,00042,0790.51%
Other shareholders
HAEMONETICS CORP shareholders Q4 2018
NameSharesValueWeighting ↓
Iron Triangle Partners LP 330,000$36,633,0004.66%
BEACONLIGHT CAPITAL, LLC 156,395$17,361,0002.80%
Bridge City Capital, LLC 48,011$5,330,0001.77%
Summit Creek Advisors LLC 121,362$13,472,0001.61%
Sivik Global Healthcare LLC 25,000$2,775,0001.01%
ANCHOR CAPITAL ADVISORS LLC 412,218$45,760,0000.97%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 69,655$7,732,0000.90%
Orbimed Advisors 852,000$94,581,0000.88%
LONDON CO OF VIRGINIA 1,057,738$117,420,0000.67%
WEXFORD CAPITAL LP 40,138$4,456,0000.66%
View complete list of HAEMONETICS CORP shareholders